Quick Facts
- TypeFat-soluble vitamin / hormone precursor
- RDA600-800 IU (many experts recommend 1,000-2,000 IU)
- Upper Limit (UL)4,000 IU/day
- Deficiency Rate~40% of US adults have insufficient levels
- D3 vs D2D3 is 87% more effective at raising serum 25(OH)D
- Strongest EvidenceBone health + depression
What Is Vitamin D
Vitamin D is a fat-soluble vitamin that functions as a hormone precursor in the body. It is synthesized in the skin upon UVB exposure and can also be obtained from fatty fish, fortified foods, and supplements. Once converted to its active form (1,25-dihydroxyvitamin D), it regulates calcium absorption, bone mineralization, immune function, and gene expression across hundreds of tissues.
Despite its critical roles, vitamin D insufficiency is remarkably common. An estimated 40% of US adults have suboptimal levels (serum 25(OH)D below 30 ng/mL), with higher rates in darker-skinned individuals, northern latitudes, and those with limited sun exposure. This widespread insufficiency has driven enormous research interest, with thousands of studies examining its effects across dozens of health outcomes.
What the Evidence Shows
| Condition | Evidence | Key Finding | Effective Dose |
|---|---|---|---|
| Bone health / fractures | Strong | Ca + Vitamin D reduced fractures in elderly (19 RCTs, 69,234 participants)[1] | 800-1,000 IU + calcium |
| Depression | Strong | SMD -0.36 (20 RCTs, p<0.00001), especially if deficient[2] | 1,000-4,000 IU/day |
| Respiratory infections | Moderate | Lower mortality in deficient COVID patients (RR 0.76)[3] | 1,000-4,000 IU/day |
| Hair loss | Moderate | 52% of AA patients deficient; OR 2.84 for AA, OR 5.24 for FPHL[4] | Correct to >30 ng/mL |
| Muscle function / falls | Moderate | Linked to muscle function; studied for fall prevention in elderly[5] | 800-2,000 IU/day |
| Immune function | Moderate | 39% reduction in URIs in nutritionally at-risk children[6] | 1,000-2,000 IU/day |
| Cardiovascular | Insufficient | No significant MACE reduction (HR 0.96)[7] | Not supported |
| Cancer | Limited | Mixed; some associations but no strong intervention data[8] | Not supported |
Deep Dives
Who Benefits Most
Vitamin D supplementation is most impactful for individuals who are already deficient or insufficient. Many of the strongest trial results come from populations with low baseline levels. Groups at highest risk of deficiency include:
- People with darker skin: Higher melanin reduces UVB-driven synthesis.
- Northern latitude residents: Insufficient UVB exposure during winter months.
- Older adults: Reduced skin synthesis capacity and often limited sun exposure.
- Obese individuals: Vitamin D is sequestered in adipose tissue, lowering bioavailability.
- Indoor workers / those who cover skin: Minimal sun exposure year-round.
- Individuals with malabsorption: Celiac disease, Crohn's, or gastric bypass patients.
Testing serum 25(OH)D is the most reliable way to determine your status. Most experts consider 30-50 ng/mL (75-125 nmol/L) the optimal range.
Forms Compared
Not all forms of vitamin D are equivalent. D3 (cholecalciferol) is the preferred form based on bioavailability data:
| Form | Source | Verdict |
|---|---|---|
| D3 (cholecalciferol) | Animal-derived (lanolin, fish oil) or lichen | Preferred. 87% more effective than D2 at raising serum 25(OH)D. |
| D2 (ergocalciferol) | Plant/fungal-derived | Vegan option. Less potent, shorter half-life, requires higher dosing. |
| Calcifediol (25(OH)D) | Pre-converted form | Faster serum rise. Useful for malabsorption or when rapid correction needed. |
Absorption tip: Vitamin D is fat-soluble. Taking it with a fat-containing meal significantly improves absorption. One study showed a 32% increase in serum levels when taken with the largest meal of the day versus on an empty stomach.
Safety and Interactions
Vitamin D is generally well-tolerated at recommended doses, but excessive intake can cause toxicity through hypercalcemia (elevated blood calcium), which may lead to nausea, kidney stones, and in severe cases, cardiovascular and renal damage.
- Tolerable Upper Intake Level (UL): 4,000 IU/day for adults. Some researchers argue this is conservative, but exceeding it without medical supervision is not recommended.
- Toxicity threshold: Generally associated with serum 25(OH)D levels above 150 ng/mL (375 nmol/L), typically from chronic intake of 10,000+ IU/day.
- Testing before high-dose supplementation: Serum 25(OH)D should be measured before starting doses above 2,000 IU/day and monitored periodically.
Drug Interactions
- Corticosteroids: Reduce calcium absorption and impair vitamin D metabolism.
- Statins: Some statins may be affected by high-dose vitamin D; monitor lipid panels.
- Thiazide diuretics: Combined with vitamin D and calcium, may increase risk of hypercalcemia.
- Orlistat: Reduces fat absorption, which can impair vitamin D uptake.
- Phenytoin / anticonvulsants: Increase vitamin D catabolism, potentially worsening deficiency.
References
- Calcium + vitamin D for fracture prevention in elderly. 19 RCTs, 69,234 participants. 2024. PubMed
- Vitamin D and depression meta-analysis (SMD -0.36). 20 RCTs, p<0.00001. 2025. PubMed
- Vitamin D and respiratory infection mortality in deficient patients (RR 0.76). 2025. PubMed
- Vitamin D deficiency and hair loss: 52% AA patients deficient, OR 2.84 AA, OR 5.24 FPHL. 2024. PubMed
- Vitamin D, muscle function, and fall prevention in elderly. 2025. PubMed
- Carboo JA, et al. "High-dose oral vitamin D supplementation for prevention of infections in children aged 0 to 59 months: systematic review and meta-analysis." Nutr Rev. 2024. 7 RCTs, 5,748 children. PubMed
- Vitamin D and cardiovascular outcomes (HR 0.96, no significant MACE reduction). 2025. PubMed
- Petrelli F, et al. "Vitamin D3 and cancer risk in healthy subjects: umbrella review." Clin Nutr ESPEN. 2024. 71 SRs; reduced cancer mortality (OR 0.90) but mixed incidence data. PubMed